AKRO
Akero Therapeutics, Inc.
54.65
1 x 53.92
2 x 70.00
bid
ask
+
0.00
0.00%
2 @ 09:30 AM
54.69 +0.04 (0.07%)
| Ytd | 96.44% | |
| 1y | 75.67% |
54.42
day range
54.83
21.34
52 week range
58.40
| Open | 54.52 | Prev Close | 54.65 | Low | 54.42 | High | 54.83 | Mkt Cap | 4.50B |
| Vol | 11.61M | Avg Vol | 2.75M | EPS | -3.75 | P/E | N/A | Forward P/E | -13.62 |
| Beta | -0.40 | Short Ratio | 2.33 | Inst. Own | 112.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 53.20 | 200-d Avg | 48.24 | 1yr Est | 56.50 |
| Income Statement | |||
| Operating Expenses | 90.24M | ||
| Research and Development Expense | 78.88M | ||
| Selling, General and Administrative Expense | 11.35M | ||
| Operating Income | -90.24M | ||
| Interest Expense | 1.09M | ||
| Net Income | -81.57M | ||
| Net Income Common Stock | -81.57M | ||
| Net Income Common Stock (USD) | -81.57M | ||
| Consolidated Income | -81.57M | ||
| Earnings per Basic Share | -0.99 | ||
| Earnings per Basic Share (USD) | -0.99 | ||
| Earnings per Diluted Share | -0.99 | ||
| Earning Before Interest & Taxes (EBIT) | -80.47M | ||
| Earning Before Interest & Taxes (USD) | -80.47M | ||
| Weighted Average Shares | 82.01M | ||
| Weighted Average Shares Diluted | 82.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 176.03M | ||
| Cash and Equivalents (USD) | 176.03M | ||
| Investments | 812.28M | ||
| Investments Current | 561.79M | ||
| Investments Non-Current | 250.49M | ||
| Current Assets | 754.54M | ||
| Property, Plant & Equipment Net | 552.00K | ||
| Total Assets | 1.01B | ||
| Total Debt | 289.00K | ||
| Current Liabilities | 47.65M | ||
| Debt Non-Current | 289.00K | ||
| Total Liabilities | 47.94M | ||
| Accumulated Retained Earnings (Deficit) | -1.05B | ||
| Accumulated Other Comprehensive Income | 1.83M | ||
| Shareholders Equity | 957.64M | ||
| Shareholders Equity (USD) | 957.64M | ||
| Assets Non-Current | 251.04M | ||
| Total Debt (USD) | 289.00K | ||
| Liabilities Non-Current | 289.00K | ||
| Trade and Non-Trade Payables | 20.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 69.00K | ||
| Net Cash Flow from Financing | -34.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -44.42M | ||
| Issuance (Purchase) of Equity Shares | 3.37M | ||
| Issuance (Repayment) of Debt Securities | -37.40M | ||
| Net Cash Flow from Investing | 56.78M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 56.78M | ||
| Net Cash Flow from Operations | -67.17M | ||
| Share Based Compensation | 9.26M | ||